The U.S. Food and Drug Administration recently approved a new vaccine that will cover more strains of the human papillomavirus virus (HPV) and have a greater reach at protecting against various cancers, including cervical.
Dr. Dean Blumberg, Chief of Pediatric Infectious Diseases at U.C. Davis Health System discusses the effect of the vaccine.